3D Printing

Abstract Microneedles (MNs) are small devices that help to overcome the skin barrier and, thus, increase the effectiveness of transdermal drug...

Abstract Excipients, historically regarded as inert, are now being recognised for their ability to actively modulate biological targets, including intestinal...

Three-dimensional (3D) printing has emerged as a transformative technology in pediatric drug delivery, offering solutions to long-standing challenges such as...

In the evolving realm of skin delivery, the shortcomings of traditional drug delivery practices have encouraged the emergence of innovative...

Abstract Parkinson’s disease (PD) is frequently complicated by dysphagia, undermining timely and reliable oral dopaminergic medication. Levodopa’s short half-life and...

Abstract The development of polymer-based systems is central to the design of next-generation drug delivery carriers, as polymers enable versatile...

Abstract Pediatric drug delivery presents unique challenges due to physiological and pharmacological differences across age groups, requiring specialized formulation approaches...

Abstract Introduction: Levodopa (LD) is the most efficacious antiparkinsonian drug. However, long-term conventional LD treatment of Parkinson’s disease (PD) is frequently...

Precision 3D Printing in Pharmaceutical Sciences: A Transformative Shift in Drug Manufacturing and Delivery Systems See the new book, edited...

Abstract Background: Digital light processing (DLP) 3D printing has emerged as a rapid alternative to labour-intensive micro-moulding for producing microneedle (MN)...